Dopamine/norepinephrine/phenylephrinePosterior reversible encephalopathic syndrome: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1718卷 / 1期

关键词：

D O I：

10.1007/s40278-018-51443-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：99 / 99

相关论文

共 50 条

[21] AntineoplasticsPosterior reversible encephalopathy syndrome: 6 case reports
Reactions Weekly, 2015, 1562 (1) : 29 - 29
[22] ImmunosuppressantsPosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2016, 1601 (1) : 144 - 144
[23] ImmunosuppressantsPosterior reversible encephalopathy syndrome: 4 case reports
Reactions Weekly, 2019, 1747 (1) : 151 - 151
[24] BevacizumabPosterior reversible leukoencephalopathy syndrome: 2 case reports
Reactions Weekly, 2012, 1390 (1) : 11 - 11
[25] RituximabPosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2019, 1772 (1) : 288 - 288
[26] MethylprednisolonePosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2014, 1485 (1) : 27 - 27
[27] TacrolimusPosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2016, 1603 (1) : 225 - 225
[28] AntineoplasticsPosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2020, 1803 (1) : 37 - 37
[29] Posterior Reversible Encephalopathy Syndrome: Two Case Reports
Tek, Seyda Cigdem
Uyar, Ahmet Senol
Cakici, Zafer
Inal, Mehmet Turan
Memis, Dilek
Tekatac, Aslan
Sayin, Cenk
Varol, Fusun
TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2019, 17 (01): : 44 - 48
[30] AntineoplasticsPosterior reversible encephalopathy syndrome: 2 case reports
Reactions Weekly, 2011, 1374 (1) : 9 - 9

← 1 2 3 4 5 →